Dr Reddy’s Settles US Patent Litigation With Intercept On Ocaliva

Five Further Firms Have Filed For Generic Obeticholic Acid

 
• By Chloe Kent
  
Book entitled 'Intellectual Property Law'
The ruling states that Dr. Reddy's will not be able to market its generic until 2035 • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin